Further research indicated that inhibition of SPP1 effectively decreases N‐cadherin and β‐catenin expression, simultaneously blocking AKT and STAT3 activation and significantly reducing tumor cell invasion and metastasis [7]. The gene discussed is SPP1; the disease is neoplasm.